Utility of serum galactomannan antigen for diagnosis and follow-up of invasive aspergillosis in hematological patients

Chinese Journal of Infection and Chemotherapy

Volumn 9, Issue 3, 2009, Pages 233-236

  Xu, Ming Zhu ^a   Sun, Ai Ning ^a   Wu, De Pei ^a   Qiu, Hui Ying ^a   Tang, Xiao Wen ^a   Fu, Zheng Zheng ^a   Jing, Zheng Ming ^a   Miao, Miao ^a   Han, Yue ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Aspergillosis; Galactomannan; Hematopoietic stem cell transplantation; Leukemia

Indexed keywords

ANTIFUNGAL AGENT; GALACTOMANNAN;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; FUNGAL DETECTION; HUMAN; MAJOR CLINICAL STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 66649128695     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mart KA, Carter RA, Boeckh M, et al. Invasive aspergiillosis in allogeneie stem cell transplant recipients: changes in epidemiology and risk factors[J]. Blood,2002,100(13):4358-4366.
2. Morgan J, Wannemuehhr KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter survellance program[J]. Med Myeol,2005,43Suppl 1:S49-S58.
3. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients[J]. J Clin Oncol,2002,20(7):1898-1906.
4. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus[J]. Clin Infect Dis,2002,34(1):7-14.
5. Mennink-Kemten MA, Donnelly JP, Verweij PE. Detection of circulating galaetomannan for the diagnosis and management of invasive aspergillosis[J]. Lancet Infect Dis,2004,4(6):349-357.
6. Mattel D, Rape zzi D, Mordini N. False-positive Aspergillus galactomannan enzyme-linked immunosorbent saasy results in vivo during amoxicillin-clavulanic acid treatment[J]. J Clin Microbiol,2004,42(11):5362-5363.
7. Marino IR, Panarelio G, Singh N. Eficacy of Aspergillus galactomannan directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients[J]. Transpl Infect Dis,2002,4(4):226-227.
8. Maertens J, Theunissen K, Verhoef G, et al. Galaetomannan and computed tomography-based preemptive antifungal therapy in neutropenie patients at high risk for invasive fungal infection: a prospective feasibility study[J]. Clin Infect Dis,2005,41(9):1242-1250.
9. Marr KA, Balajee SA, McLaughlin L, et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance[J]. J Infect Dis,2004,190(3):641-649.